Maternal plasma DNA testing for aneuploidy in pregnancies achieved by assisted reproductive technologies
Language English Country United States Media print-electronic
Document type Comparative Study, Journal Article
PubMed
24091801
DOI
10.1038/gim.2013.149
PII: S1098-3600(21)04820-6
Knihovny.cz E-resources
- MeSH
- Aneuploidy * MeSH
- Reproductive Techniques, Assisted adverse effects MeSH
- DNA blood genetics MeSH
- Down Syndrome diagnosis epidemiology genetics MeSH
- Genetic Testing MeSH
- Humans MeSH
- Pregnancy MeSH
- Check Tag
- Humans MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
- Names of Substances
- DNA MeSH
PURPOSE: We sought to compare measurements of circulating cell-free DNA as well as Down syndrome test results in women with naturally conceived pregnancies with those conceived using assisted reproductive technologies. METHODS: Data regarding assisted reproductive technologies were readily available from seven enrollment sites participating in an external clinical validation trial of nested case/control design. Measurements of circulating cell-free fetal and total DNA, fetal fraction (ratio of fetal to total DNA), chromosome-specific z-scores, and karyotype results were available for analysis. RESULTS: Analyses were restricted to 632 euploid (5.2% assisted reproductive technologies) and 73 Down syndrome (13.7% assisted reproductive technologies), including 16 twin pregnancies. No differences were found for fetal or total circulating cell-free DNA, or for the fetal fraction in euploid (P = 0.70) or Down syndrome (P = 0.58) pregnancies by method of conception. There appeared to be systematic z-score reductions for chromosomes 21, 18, and 13 in assisted reproductive technologies versus natural euploid pregnancies (P = 0.048, 0.0032, and 0.36, respectively). CONCLUSION: Assisted reproductive technologies and naturally conceived pregnancies contribute similar levels of circulating cell-free DNA into maternal circulation. Small differences in the z-scores of pregnancies achieved by assisted reproductive technologies were observed and do not appear to be test-related artifacts. However, the findings need confirmation before any consideration of changes to testing and reporting protocols.
Department of Genetics Yale University New Haven Connecticut USA
Department of Obstetrics and Gynecology Brigham and Women's Hospital Boston Massachusetts USA
Department of Obstetrics and Gynecology Cedars Sinai Medical Center Los Angeles California USA
Hospital Clinic Barcelona Barcelona Spain
IMALAB s r o Medical Laboratories Zlin Czech Republic
Istituto G Gaslini Genova Italy
Sequenom Center for Molecular Medicine San Diego California USA
References provided by Crossref.org